Timothy C Wentworth
CIK 1252016 · Chief Executive Officer · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
108 WILMOT ROAD
DEERFIELD, IL 60015
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| DGX | Director | 1,358 | $241.43 | $327.9K | $0 | 5 | 2026-10-02 |
| Walgreens Boots Alliance, Inc. (WBA) Delisted | Chief Executive Officer | 0 | $11.98 | $0 | $242.2K | 4 | 2025-08-28 |
| CI | CEO Evernorth | 61,267 | $302.77 | $18.55M | -$27.14M | 20 | 2021-05-13 |
| Express Scripts Holding Co. (ESRX) Delisted | President & CEO | 0 | — | — | $489.0K | 21 | 2018-12-21 |
| MEDCO HEALTH SOLUTIONS INC (MHS) Delisted | Group Pres, Employer Accounts | 0 | — | — | -$19.12M | 28 | 2012-04-03 |
Recent Filings · Page 3 of 8
78 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-02-28 | CI | Grant (A) | +7,812 | $0 | EDGAR |
| 2020-02-11 | CI | Sell (S) | −21,708 | -$4.55M | EDGAR |
| 2020-02-06 | CI | Mixed | −3,910 | -$767.6K | EDGAR |
| 2019-11-21 | CI | Mixed | −14,451 | -$553.0K | EDGAR |
| 2019-05-07 | CI | Tax (F) | −1,658 | -$253.4K | EDGAR |
| 2019-03-04 | CI | Tax (F) | −10,472 | -$1.83M | EDGAR |
| 2019-03-01 | CI | Grant (A) | +8,178 | $0 | EDGAR |
| 2019-02-05 | CI | Mixed | +31,339 | $0 | EDGAR |
| 2018-12-26 | CI | Mixed | +295,933 | $0 | EDGAR |
| 2018-12-21 | Express Scripts Holding Co. (ESRX) Delisted | Mixed | −292,515 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.